Влияние поражения костного мозга на клинико-лабораторные особенности неходжкинских лимфом
Диссертация
Научная новизна. Впервые на репрезентативном клиническом материале, включающем 202 первичных больных НЛ с морфологически идентифицированным вариантом заболевания (в соответствии с ВОЗ — классификацией, 2001 г.), проанализировано влияние поражения костного мозга на основные клинические и лабораторные показатели у больных индо-лентными и агрессивными НЛ и эффективность химиотерапии первой линии… Читать ещё >
Список литературы
- Бармина Н.М., Двойрина В. В. Статистика злокачественных лим-фом в 1990 году // Современные методы диагностики и лечения злокачественных лимфом. СПб. — 1992. — С. 13−14.
- Биоптаты костного мозга в диагностике болезней системы крови и вторичных нарушений кроветворения / Под ред. А. И. Воробьева. — М.: Медицина, 1989.-31 с.
- Клиническая онкогематология / Под ред. М. А. Волковой. М.: Медицина, 2001. — 576 с.
- Новик А.А. Классификация злокачественных лимфом (рекомендации ВОЗ) // Санкт-Петербург, «Элби», 2000. 125 с.
- Салтыкова Л.Б., Криволапов Ю. А. Иммунологические маркеры в гистологической диагностике лимфом // Тер. архив. — 2002. N. 7. — С. 8087.
- Яворковский Л. Л. Гистологическое и иммуногистохимическое исследование костного мозга при некоторых видах гемобластозов, новые возможности трепанобиопсии // Автореф. дис.. докт. мед. наук. Л., 1991.-34 с.
- Achten R., Verhoef G., Vanuytsel L., Wolf-Peeters C. T-cell / Histio-cyte-Rich large В cell lymphoma // J. Clin. Oncol. — 2002. — Vol. 20, N. 5. — P. 1269−1277.
- Ahmann D.L., Kiely J.M. Malignant lymphoma of the spleen: a review of 49 cases in which the diagnosis was made at splenectomy // Cancer. — 1996. — Vol. 19, N. 1.-461−469.
- Ahn M.J., Kim H., Kim I.S. et al. p53 protein expression and its prognostic importance in patients with nodal non-Hodgkin's lymphoma // J. Korean. Med. Sci.-2000.-Vol. 15, N. l.-P. 59−64.
- Anagnostopoulos I., Hummel M., Finn T. et al. Heterogeneous Ep-stein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type // Blood. 1992. — Vol. 80, N. 1. — P. 18 041 808.
- Andersen N.S., Donovan J.W., Borus J.S. et al. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease // Blood. — 1997. — Vol. 90, N. 1. P. 4212−4216.
- Apostolidis J., Gupta R.K., Grenzelias D. et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up // J. Clin. Oncol. 2000. — Vol. 18, N.3.-P. 527−536.
- Anderson R.J., Vose J.M., Bierman PJ. et al. Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska lymphoma study group // J. Clin. Oncol. 1993. — Vol. 11, N. 2. -P.218−224.
- Ansell S., Kurtin P., Stenson M. et al. Evaluation of the proliferative index as a prognostic factors in diffuse large cell lymphoma: correlation with the IPI // Leukemia Lymphoma. — 1999. — Vol. 34, N. 5. — P. 529−537.
- Argatoff L.H., Connors J.M., Klasa R.J. et al. Mantle cell lymphoma: a clinicopathological study of 80 cases // Blood. 1997. — Vol. 89, N. 6. -P.2067−2078.
- Arias V., Soares F.A. Vascular density (tumor angiogenesis) in non-Hodgkin's lymphomas and florid follicular hyperplasia: a morphometric study // Leuk.-Lymphoma. 2000. — Vol. 40, N. 1−2. — P. 157−166.
- Armitage J.O., Coiffier B. Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma // Ann. Oncol. 2000. — Vol. 11, N. 1. — P. 1−8.
- Armitage J.O., Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project // J. Clin. Oncol. 1998. — Vol. 16, N. l.-P. 2780−2791.
- Baar J., Burkes R.L., Gospodarowicz M. Primary non-Hodgkin's lymphoma of bone // Semin. Oncol. 1999. — Vol. 26, N. 3. — P. 270−275.
- Bain B.J. Bone marrow aspiration // J. Clin. Pathol. 2001. — Vol. 54, N. 2.-P. 657−663.
- Bain B.J. Bone marrow trephine biopsy // J. Clin. Pathol. 2001. -Vol. 54, N. 2.-P. 737−742.
- Bartl R., Frish B., Burkhardt R., Jager K. Lymphoprolipheration in bone marrow, identification and evolution, classification and staging // J. Clin. Oncol. 1984. — Vol. 37, N. 10. — P. 233−254.
- Bartlett N.L., Rizeg M., Dorfman R.F. et al. Follicular large-cell lymphoma: intermediate or low grade? // J. Clin. Oncol. 1994. — Vol. 12, N. 7. -P. 1349−1357.
- Bastion Y., Berger F., Coiffier B. et al. Follicular lymphoma: assessment of prognostic factors in 127 patients followed for 10 years // Ann. Oncol. -1991.-Vol. 2.-P. 123−129.
- Bastion Y., Coiffier B. Is the PI for aggressive lymphoma patients useful for follicular lymphoma patients // J. Clin. Oncol. 1994. — Vol. 12, N. 7.-P. 1340−1342.
- Bennet J.M., Cain C.K., Glick J.H. et al. The significance of bone marrow involvement in non-Hodgkin's lymphoma: The Eastern Cooperative Oncology Group Experience // J. Clin. Oncol. 1986. — Vol. 4, N. 10. — P. 1462−1469.
- Berger F., Felman P., Thieblemont C. et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients//Blood.-2000.-Vol. 95, N. l.-P. 1950−1960.
- Bernard J. et al. Follicular Lymphoma International Prognostic Project (FLIPP)// Annals of Oncology, Volume 13, 2002 Supplement 2: 8th International Conference on Malignant Lymphw3oma, 12−15 June, 2002: Lugano, Switzerland
- Bosch F., Lopez-Guillermo A., Campo E. et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors // Cancer. 1998. — Vol. 82, N. 1. — P. 567−573.
- Boussiotis V.A., Freedman A.S., Nadler L.M. Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia // Semin. Hematol. 1999. — Vol. 36, N. 2. — P. 209−216.
- Braunschweig R., Baur A.S., Delacretaz F. et al. Contribution of IgH PCR to the evaluation of B — cell lymphoma involvement in paraffin — embedded bone marrow biopsy specimens // Am. J. Clin. Phatol. — 2003. — Vol. 119 — P. 634−642.
- Bremnes R.M., Bremnes Y., Donnem T. High grade non-Hodgkin's lymphoma treated in northern Norway: treatment, outcome, prognostic factors // Acta Oncol. 1999. — Vol. 38, N. 1. — P. 117−124.
- McBride J.A., Rodriguez J., Luthra R. et al. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin’s disease see comments. // Am. J. Surg. Pathol. 1996. — Vol. 20, N. 1. — P. 193−199.
- Buchmann I., Moog F., Schirrmeister H., Reske S.N. Positron emission tomography for detection and staging of malignant lymphoma // Recent Results Cancer Res. 2000. — P. 15 678−15 689.
- Burkhardt R., Frish B., Bartl R. Bone biopsy in haematological disorders // J. Clin. Pathol. 1982. — Vol. 35. — P. 257−284.
- Campo E., Miquel R., Krenacs L. et al. Primary nodal marginal zone lymphomas of splenic and MALT type // Am. J. Surg. Pathol. 1999. — Vol. 23, N. l.-P. 59−64.
- Carbone A., Gloghini A., Pinto A. et al. Monocytoid B-cell lymphoma with bone marrow and peripheral blood involvement at presentation see comments. // Am. J. Clin. Pathol. 1989. — Vol. 92, N. 1. — P. 228−231.
- Catovsky D., Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma // Semin. Hematol. 1999. -Vol. 36, N. l.-P. 148−153.
- Cecyn K.Z., Oliveira J.S., Alves A.C. et al. Prognostic factors in non-Hodgkin lymphomas // Sao. Paulo. Med. J. 2000. — Vol. 118, N. 1. — P. 7−12.
- Chao N.J., Rosenberg S.A., Horning S.J. CEPP (B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma // Blood.-1990.-Vol. 76, N. l.-P. 1293−1296.
- Chim C.S., Chan A.C., Choo C.K. et al. Mantle cell lymphoma in the Chinese: clinicopathological features and treatment outcome// Am. J. Hematol. 1998.-Vol. 59, N.4. — P. 295−301.
- Ching H.Y., Horsman J.M., Radstone C.R. et al. Non-Hodgkin's lymphoma presenting with spinal involvement: the Sheffield Lymphoma Group experience (1970−2000)//Int. J. Oncol.-2001.-Vol. 19, N.l. -P. 149−156.
- Chisesi T., Polistena P., Contu A. et al. Cemp, a mitoxantrone containing combination in the treatment of intermediate and high grade non-Hodgkin's lymphoma // Leikemia Lymphoma. — 2001. — Vol. 41, N. l-2. — P. 125−136.
- A clinical evaluation of International Lymphoma Study Group classification of non-Hodgkin's Lymphoma. The Non-Hodgkin's Lymphoma Classification Project // Blood. 1997. — Vol. 89, N. 1. — P. 3909−3914.
- Cogliatti S.B., Lennert K., Hansmann M.L., Zwingers T.L. Monocy-toid B-cell lymphoma: clinical and prognostic features of 21 patients // J. Clin. Pathol. 1990. — Vol. 43, N. 6. — P. 619−625.
- Cohen P.L., Kurtin P.J., Donovan K.A. et al. Bone marrow and peripheral blood involvement in mantle cell lymphoma // Br. J. Haem. — 1998. — Vol. 101, N. 2. P. 302−310.
- Coiffier B. Non-Hodgkin's lymphomas: clinical presentation, treatment and outcome // Basel, Switzerland. — 2001. — P. 73.
- Coiffier B. Which treatment for Mantle-cell lymphoma patients in 1998? // J. Clin. Oncol. 1998. — Vol. 16, N.l. — P. 3−5.
- Coiffier B., Haioun C., Ketterer N. et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study // Blood. — 1998. Vol. 92, N. 1. — P. 1927−1934.
- Conill C., Verger E., Salamero M. et al. Performance status assessment in cancer patients // Cancer. 1990. — Vol. 65. — P. 1864−1866.
- Conlan M.G., Bast M., Armitage J.O., Weisenburger D.D. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow // J. Clin. Oncol. 1990. Vol. 8, N. 7. — P. 1163−1165.
- Cooke C.B., Krenacs L., Stetler-Stevenson M. et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin see comments. // Blood. 1996. — Vol. 88, N. 1. — P. 4265−4272.
- Cooper I.A., Wolf M.M., Robertson T.I. et al. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma // J. Clin. Oncol. 1994. — Vol. 12, N. 4. — P. 769−778.
- Copelan E.A., Penza S.L., Pohlman B. et al. Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma // Bone Marrow Transplant. 2000. — Vol. 25, N. 12. — P. 1243−1248.
- Crisan D., Mattson J. Discordant morphologic features in bone marrow involvement by malignant lymphomas // Am. J. Hemathol. 1995. — Vol. 49.-P. 299−309.
- Cuneo A., Bigoni R., Rigolin G. M. et al. Acquired chromosome llq deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkiris lymphoma: correlation with clinicobiologic features // J. Clin. Oncol. 2000. — Vol. 18, N. 13.-P. 2607−2614.
- Czuczman M.S., Grillo-Lopez A.J., White C.A. et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy // J. Clin. Oncol. 1999. -Vol. 17, N. l.-P. 268−276.
- Danieu L., Wong G., Koziner B. et al. Predictive model for prognosis in advanced diffuse Histiocitic lymphoma // Cancer. Res. 1986. — Vol. 46, N. l.-P. 5372−5379.
- Denham J.W., Denham E., Dear K.B. et al. The follicular non-Hodgkin's lymphomas-I: the possibility of cure // Eur. J. Cancer. 1996. — Vol. 32A, N. 3. — P. 470−479.
- Diez-Martin J.L., Lust J.A., Witzig T.E. et al. Unusual presentation of extranodal peripheral T-cell lymphomas with multiple paraneoplastic features // Cancer. 1991. — Vol. 68, N. 1. — P. 834−839.
- Dillman R.O. Radiolabeled anti-CD 20 monoclonal antibodies for the treatment of B-cell lymphoma // J. Clin. Oncol. 2002. — Vol. 20, N. 16. — P. 3545−3557.
- Dobson L.S., Hancock H., Bright N. et al. Localised non-Hodgkin's lymphoma: the Sheffield Lymphoma Group experience (1970−1995) // Int. J. Oncol.-1998.-Vol. 13, N. 6.-P. 1313−1318.
- Dorfman D.M., Pinkus G.S. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23 // Mod. Pathol. -1994. — Vol. 7, N. l.-P. 326−331.
- Dubus P., Young P., Beylot-Barry M. et al. Value of interphase FISH for diagnosis of t (ll-14)(ql3-q32) on skin lesions of Mantle cell lymphoma // Am. J. Clin. Pathol. 2002. — Vol. 118. — P. 832−841.
- Eek R., Falkson G. The low-grade lymphoproliferative disorders // Oncology. 1997. — Vol. 54, N. 6. — P. 441−458.
- Engert A., Wolf J., Diehl V. Treatment of advanced Hodgkin’s lymphoma: standard and experimental approaches // Semin. Hematol. 1999. — Vol. 36, N.3.-P. 282−289.
- Etienne B., Guillaud P.H., Loire R. et al. Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases // Eur. Respir. J. 1999. -Vol. 13, N. 5.-P. 1133−1138.
- Falini B., Fizzotti M., Pileri S. et al. Bcl-6 protein expression in normal and neoplastic lymphoid tissues // Ann. Oncol. 1997. — Vol. 8, N. l.-P. 101−108.
- Farcet J.P., Gaulard P., Marolleau J.P. et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta // Blood. 1990. — Vol. 75, N. 1. — P. 2213−2217.
- Faulkner B.E., Howie A J., Boughton B.J. et al. Lymphoid aggregates in bone marrow: study of eventual outcome // J. Clin. Phathol. 1988. — Vol. 41.-P. 768−775.
- Federico M., Vitolo U., Zinzani P.L. et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases // Blood. 2000. — Vol. 95, N. 3. — P. 783−789.
- Fisher D.E., Jacobson J.O., Ault K.A. et al. Diffuse large cell lymphoma with discordant bone marrow histology // Cancer. 1989. — Vol. 648, N.9.-P. 1879−1887.
- Foucar K., McKenna R.W., Frizzera G. et al. Bone marrow and blood involvement by lymphoma in relationship to the Lukes Collins classification // Cancer. — 1982. — Vol. 49, N.5. — P. 888−897.
- Fraga M., Brousset P., Schlaifer D. et al. Bone marrow involvement in Anaplastic large cell lymphoma // Am. J. Clin. Pathol. 1995. — Vol. 103, N.l.-P. 82−89.
- Francois A., Lesesve J.F., Stamatoullas A. et al. Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromisedpatients, associated with isochromosome 7q // Am. J. Surg. Pathol. 1997. -Vol. 21, N. l.-P. 781−790.
- Gallagher C.J., Gregory W.M., Jones A.E. et al. Follicular lymphoma: prognostic factors for response and survival // J. Clin. Oncol. 1986. — Vol. 4, N. 10.-P. 1470−1480.
- Gascoyne R.D., Adomat S.A., Krajewski S. et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma // Blood. 1997. — Vol. 90, N. 1. — P. 244 251.
- Garvin A. J., Simon R.M., Osborne C.K. et al. An autopsy study of histologic progression in non-Hodgkin's lymphomas // Cancer. 1983. — Vol. 52, N.3.-P. 393−398.
- Gisselbrecht C., Lepage E., Molina T. et al. Shortened first-line highdose chemotherapy for patients with poor prognosis aggressive lymphoma // J. Clin. Oncol. 2002. — Vol. 20, N. 10. — P. 2472−2479.
- Glass A.G., Karnell L.H., Menck H.R. The National Cancer Data Base report on non-Hodgkin's lymphoma // Cancer. 1997. — Vol. 80, N. l.-P. 2311−2321.
- Greiner T.C., Moynihan M.J., Chan W.C. et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis // Blood. 1996. — Vol. 87, N. 1. — P. 4302−4307.
- Groves F.D., Linet M.S., Travis L.B., Devesa S.S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995 // J. Natl. Cancer Inst. 2000. — Vol. 92, N. 15. -P. 1240−1251.
- Hag R., Sawka C.A., Franssen E. et al. Mitoxantrone DHAP with GM — CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma // Leuk — Lymphoma. — 1999. — Vol. 35, N. 5−6. — P. 527−536.
- Hainsworth J.D., Burns H.A., Morrissey L.H. et al. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma // Blood. 2000. — Vol. 95, N. 10. — P. 3052−3056.
- Hanel M., Kroger N., Kroschinsky F. et al. Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma // J. Cancer. Res. Clin. Oncol. 2001. — Vol. 127, N. 6.-P. 387−395.
- Hanson C.A., Brunning R. D, Gajl-Peczalska K.J. et al. Bone marrow manifestations of peripheral T — cell lymphoma // Am. J. Clin. Pathol. 1986. — Vol. 86, N. 4.-P. 449−460.
- Harris N.L., Jaffe S., Armitage J. et al. Lymphoma classification: from R.E.A.L. to W.H.O. and beyond // Cancer: Principles and Practice of Oncology Updates. 1999. — Vol. 13, N. 3. — P. 1−14.
- Harris N.L., Jaffe E.S., Stein H. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group see comments. // Blood. 1994. — Vol. 84, N. 5. — P. 1361−1370.
- Hayward R. L., Leonard R. C. F., Prescott R. J. et al. A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma // Br. J. Cancer. 1991. — Vol. 63, N. 6. — P. 945−952.
- Heinz R., Hopfinger G., Tuchler H. Outcome of patients with low-grade B cell non-Hodgkin lymphoma and initial bone marrow involvement // Leukemia. 1997. — Vol. 11, N. 2. — P. 52−54.
- Henry IC, Bennet M.H., Farrer-Brown G. Morphological classification of non-Hodgkin's lymphomas // Recent Results Cancer Res. 1978. — Vol. 64, N. 1.-P. 38−56.
- Hermans J., Krol A.D., van-Groningen K. et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades // Blood. 1995. — Vol. 86, N. 4. — P. 1460−1463.
- Hoane B.R., Shields A.F., Porter B.A. et al. Detection of lymphoma-tous bone marrow involvement with magnetic resonance imaging // Blood. — 1991. Vol. 78, N. 3. -P. 728−738.
- Hodges G.F., Lenhardt T.M., Cotelingam J.D. Bone marrow involvement by in large cell lymphoma // Am. J. Clin. Pathol. — 1994. — Vol. 101, N.3. — P. 305−311.
- Hoffman R., Benz E.J., Sanford J. et al. Hematology Basic Principles and Practice // Churchill Livingstone, London. 2000. — P. 1294.
- Hu W., Chen M., Sun Y. et al. Multivariate prognostic analysis of stage 1(E) primary non-Hodgkin's lymphomas of the nasal cavity // Am. J. Clin. Oncol. 2001. — Vol. 24, N. 3. — P. 286−289.
- Hunt J.P., Chan J.A., Samoszuk M. et al. Hyperplasia of mantle / marginal zone B cells with clear cytoplasm in peripheral lymph nodes // Am. J. Clin. Pathol. 2001. — Vol. 116, N. 4. — P. 550−559.
- Inagaki H., Bannos S., Wakita A. et al. Prognostic significance of CD 44v in diffuse large B-cell lymphoma // Mod. Pathol. 1999. — Vol. 12, N. 5.-P. 546−552.
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive Non-Hodgkin's lymphoma // N. Engl. J. Med. 1993. — Vol. 1, N. 1. — P. 987−994.
- Isaacson P.G. Mucosa-assoriated lymphoid tissue lymphoma // Semin. Hematol. 1999. — Vol. 36, N. 1. — P. 139−145.
- Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. // Lyon: IARC Press.-2001.-P.351.
- Jagannath S., Velasquez W.S., Tucker S.L. et al. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma // J. Clin. Oncol. 1986. — Vol. 4, N. 1. — P. 859−864.
- James H., Jandl M. D. Organ involvement in NHLs // Blood: Pato-physiology. Boston, 1991. — Vol. 1, N. 1. — P. 398−407.
- Juneja K.S., Wolf M.M., Cooper LA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma // J. Clin. Phatol. 1990. -Vol. 43.-P. 630−632.
- Kass L. Bone marrow interpretation // Philadelphia. 1985. — P. 134−159.
- Kelsen N., Michalski W., Bentzen S.M. et al. Risk factors for central nervous system involvement in non-Hodgkins lymphoma // Acta Oncol.. — 1996. Vol. 35, N. 6. — P. 703−708.
- Khouri I.F., Romaguera J., Kantaijian H. et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma // J. Clin. Oncol. 1998. -Vol. 16, N. l.-P. 3803−3809.
- Kim Y.S., Ford R.J., Faber J.A. et al. B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with interfol-licular pattern // Am. J. Clin. Pathol. 2000. — Vol. 114 — P. 41−46.
- Kluin P.M., van Krieken J.H., Kleiverda K. et al. Discordant morphologic characteristic s of B-cell lymphomas in bone marrow and lymph node biopsies // Am. J. Clin. Pathol. 1990. — Vol. 94, N.l.-P. 59−60.
- Kluin-Nelemans H.C., Zagonel V., Anastasopoulou A. et al. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study // J. Nat. Cancer Inst. 2001. — Vol. 93, N. 1. — P. 22−30.
- Kramer M.H., Hermans J., Parker J. et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study//J. Clin. Oncol.-1996.-Vol. 14, N. 1.-P. 2131−2138.
- Kwak L.W., Halpern J., Olshen R.A., Horning S.J. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma // J. Clin. Pathol. 1990. — Vol. 8, N. 6. — P. 963−977.
- Lardelli P., Bookman M.A., Sundeen J. et al. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations // Am. J. Surg. Pathol. 1990. — Vol. 14, N. 1. -P. 752−761.
- Lazzarino M., Orlandi E., Paulli M. et al. Treatment outcome and prognostic factors for primary mediastinal B-cell lymphoma: a multicenter study of 106 patients // J. Clin. Oncol. 1997. — Vol. 15, N. 4. — P. 1646−1653.
- Lei K.I., Johnson P.J. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas // Cancer. 2000. — Vol. 89, N. 6. — P. 1387−1395.
- Lennert K., Feller A.C. Histopathology of Non-Hodgkin's lymphomas (Based on the Updated Kiel Classification) // Berlin: Springer Verlag. — 1992.-P. 104−112.
- Linden A., Zankovich R., Theissenen P. et al. Malignant lymphoma: bone marrow imaging versus biopsy // Radiology. 1989. — Vol. 173, N.2. — P. 335−339.
- Lo Coco F., Gaidano G., Louie D.C. et al. p53 mutations are associated with histologic transformation of follicular lymphoma // Blood. 1993. — Vol. 82, N. 1. — P. 2289−2298.
- Lopez-Guillermo A., Montserrat E., Bosch F. et al. A study of prognostic factors and assessment of five recently proposed predictive systems // J. Clin. Oncol. 1990. — Vol. 8, N. 4. — P. 615−622.
- Lopez-Guillermo A., Montserrat E., Bosch F. et al. Applicability of the IPI for aggressive lymphomas to the patients with low-grade lymphoma // J. Clin. Oncol. 1994. — Vol. 12, N. 7. — P. 1343−1348.
- Lopez-Guillermo A., Montserrat E., Reverter J.C. et al. Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems // Leukemia Lymphoma. — 1992. — Vol. 10. — P. 101 109.
- Louie D.C., Offit K., Jaslow R. et al. p53 overexpression as a marker of poor prognosis in mantle-cell lymphomas with t (l I-14)(ql3-q32) // Leukemia and Lymphoma.-1993.-Vol. 10-P. 101−109.
- Lukes R.J., Collins R.D. New approaches to the classification of lymphoma // Brit. J. Cancer. 1975. — Vol. 31, Suppl. II. — P. 1−28.
- Lyons J.A., Myles J., Pohlman B. et al. Treatment and prognosis of primary breast lymphoma: a review of 13 cases // Am. J. Clin. Oncol. 2000. -Vol. 23, N. 4.-P. 334−336.
- Maes B., Achten R., Demunter A. et al. Evaluation of B-cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemis-try, and molecular analysis // J. Clin. Pathol. 2000. — Vol. 53, N. 6. — P.835 -840.
- Magrath I.T. Management of high grade lymphomas // Oncology (Huntingt). 1998. — Vol.12, N. 8. — P. 40−48.
- Majlis A., Pugh W.C., Rodrigues M.A. et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants//!. Clin. Oncol.-1997.-Vol. 15, N. l.-P. 1664−1669.
- Medeiros L.J., Lardelli P., Stetler-Stevenson M. et al. Genotypic analysis of diffuse, mixed cell lymphomas. Comparison with morphologic and immunophenotypic findings // Am. J. Clin. Pathol. 1991. — Vol. 95, N. 1. — P. 547−551.
- Migliazza A., Martinotti S., Chen W. et al. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma //Proc. Natl. Acad. Sci. USA. 1995. -N. 92. — P. 12 520−12 525.
- Mikhaeel N.G., Timothy A.R., O’Doherty M.J. et al. 18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT // Leuk.-Lymphoma. 2000. — Vol. 39, N. 5−6. — P. 543 553.
- Miller T.P., Grogan T., Dahlberg S. et al. Prognostic significance of the Ki-67-associated proliferation antigen in aggressive non-Hodgkin's lymphomas // Blood. 1994. — Vol. 83. — P. 1460−1468.
- Mirza I., Macpherson N., Paproski S. et al. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunopheno-typic and molecular features // J. Clin. Pathol. 2002. — Vol. 20, N. 3. — P. 647 655.
- Morrison V., Frizzera G., Arthur D.C. et al. Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adults // Am. J. Hematol. 1994. — Vol. 46, N. 4. — P. 295−303.
- Mounier N., Morel P., Haioun C. et al. A multivariate analysis of the survival of patients with aggressive lymphoma // Cancer. 1998. — Vol. 82, N. 10.-P. 1952−1962.
- Mulligan S.P., Matutes E., Dearden C., Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases //Br. J. Haematol. 1991. — Vol. 78, N. 1. — P. 206−212.
- Nathwani B.N., Drachenberg M.R., Hernandez A.M. et al. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma) // Semin. Hematol.-1999.-Vol. 36, N. l.-P. 128−136.
- Nicolaides C., Fountzilas G., Zoumbos N. et al. Diffuse large cell lymphoma: identification of prognostic factors and validation of the International non-Hodgkin's lymphoma prognostic Index // Oncology. — 1998. — Vol. 55, N.5. P. 405−415.
- Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma // Blood. 1997. — Vol. 89, N. 1. — P. 3909−3918.
- Oeschger S., Brauninger A., Kuppers R., Hansmann M.L. Tumor cell dissemination in follicular lymphoma // Blood. — 2002. Vol. 99, N. 6. — P. 2192−2198.
- Offit K., Wong G., Filippa D.A. et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations //Blood.- 1991.-Vol. 77, N. l.-P. 1508−1512.
- Perry A.R., Goldstone A.H. High-dose therapy for diffuse large-cell lymphoma in first remission // Ann. Oncol. 1998. — Vol. 9, Suppl. l.-P. S9-S14.
- Peterson B.A. Current treatment of follicular low-grade lymphomas // Semin. Oncol. 1999. — Vol. 26, N. 5, Suppl. 14. — P. 2−11.
- Pezzella F., Munson P.J., Miller K.D. et al. The diagnosis of low-grade peripheral B cell neoplasms in bone marrow trephines // Br. J. Haematol. — 2000. — Vol. 108, N.2. — P. 369−376.
- Pileri S., Bocchia M., Baroni C.D. et al. Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases // Br. J. Haematol. 1994. — Vol. 86, N. 1. — P. 513−521.
- Pirc-Danoewinata H., Chott A., Onderka E. et al. Karyotype and prognosis in non-Hodgkin lymphomas // Leukemia. 1994. — Vol. 8, N. 1. — P. 1929−1942.
- Pitaluga S., Wiodarska I., Pulford K. et al. The monoclonal antibody ALKI identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements // Am. J. Pathol. 1997. -Vol. 151, N. l.-P. 343−346.
- Pittaluga S., Ayoubi T.A., Wiodarska I. et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas // J. Pathol. -1996.-Vol. 179, N. l.-P. 145−149.
- Polish L. B., Cohn D. 1., Ryder J. W., Myers A. M. Pulmonary non-Hodgkin's lymphoma in AIDS // Chest. 1989. — Vol. 96. — P. 1321-1326.
- Prognostic factors in aggressive non-Hodgkin's lymphoma // Malignant lymphomas: biology and treatment. Ed. Pangalis G.A.- Springer-Verlag Berlin Heidelberg. 1995. -P.103−127.
- Pulford K., Lamant L., Morris S.W. et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NMP)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALKI // Blood.-1997.-Vol. 89, N. l.-P. 1394−1398.
- Robertson L.E., Redman J.R., Butler J J. et al. Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical pathologicentity associated with a continuous risk of relapse // J. Clin. Oncol. 1991. — Vol. 9, N.2.-P. 236−242.
- Rodriguez M.A., Ford R.J., Goodacre A. et al. Chromosome 17p and p53 changes in lymphoma // Br. J. Haematol. 1991. — Vol. 79, N. 4. — P. 575 582.
- Romaguera J.E., McLaughlin P., North L. et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma // J. Clin.Oncol. 1991. — Vol. 9. — P. 762−769.
- Romaguera J.E., Pugh W., Luthra R. et al. The clinical relevance of t (14−18)/BCL-2 rearrangement and del 6q in diffuse large cell lymphoma and immunoblastic lymphoma // Ann. Oncol. 1993. — Vol. 4, N. 1. — P. 51−56.
- Salhany K.E., Feldman M., Kahn M.J. et al. Hepatosplenic gamma-delta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation // Hum. Pathol. 1997. — Vol. 28, N. l.-P. 674−679.
- Salhany K.E., Macon W.R., Choi J.K. et al. Subcutaneous pannicu-litis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes // Am. J. Surg. Pathol. — 1998. -Vol. 222, N. l.-P. 881−889.
- Sanchez E., Chacon I., Plaza M.M. et al. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins//J. Clin. Ocol. 1998. — Vol. 16, N. l.-P. 1931−1938.
- Sander C.A., Yano T., Clark H.M. et al. p53 mutation is associated with progression in follicular lymphomas // Blood. 1993. — Vol. 82, N. l.-P. 1994−2004.
- Sanz L., Lopez — Guillermo A., Martinez C. et al. Risk of relapse and clinicopathological features in 103 patients with diffuse large-cell lymphoma in complete response after first line treatment // Eur. J. Haematol. — 1998. — Vol. 61, N. l.-P. 59−64.
- Schlegelberger B., Feller A., Godde E. et al. Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy // Cancer Genet. Cytogenet. 1990. — Vol. 50, N. 1. — P. 15−18.
- Schmid C., Isaacson P.G. Bone marrow trephine biopsy in lym-phoproliferative disease // J. Clin. Pathol. 1992. — Vol. 45. — P. 745 — 750.
- Schouten H.C., Sanger W.G., Weisenburger D.D. et al. Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma // Cancer Genet. Cytogenet. 1990. — Vol. 47, N. 3. — P. 73−77.
- Seneviratne L., Espina B.M., Nathwani B.N. et al. Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patient with acquired immunodeficiency syndrom related lymphoma // Blood. — 2001. — Vol. 98, N. 8. — P.2358 — 2363.
- Shapira M.Y., Caspi O., Amir G. et al. Gastric-mucocutaneous gd T cell lymphoma: possible association with Epstein-Barr virus? // Leuk. Lymphoma. 1999. — Vol. 35, N. 1. — P. 397−402.
- Shields A.F., Porter B.A., Churchley S. et al. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. // J. Clin. Oncol. 1987. — Vol. 5, N. 2. — P.225 — 230.
- Shipp M.A. Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has high risk disease? // Blood. 1994. — Vol. 83, N. 5. — P. 11 651 173.
- Shipp M.A., Abeloff M.D., Antman K.H. et al. International consensus conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury // Ann. Oncol. -1999.-Vol. 10, N. l.-P. 13−19.
- Sibaud V., Beylot-Barry M., Thiebaut R. et al. Bone marrow histopa-tologic and molecular staging in epydermotrophic T — cell lymphomas // Am. J. Clin. Pathol. -2003.-Vol. 119.-P. 414−423.
- Skinnider B.F., Connors J.M., Sutcliffe S.B., Gascoyne R.D. Anaplastic large cell lymphoma: a clinicopathologic analysis // Hematol. Oncol. 1999.-Vol. 17, N. l.-P. 137−144.
- Stokke T., Galteland E., Holte H. et al. Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma // Int. J. Cancer. 2000. — Vol. 89, N. 4.-P. 313−324.
- Tang S.C., Visser L., Hepperle B. et al. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases // J. Clin. Oncol. 1994. — Vol. 12, N. l.-P. 149−158.
- Taniguchi T., Fujita A., Takahashi S. et al. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies // Jpn. J. Cancer Res. — 1998. — Vol. 89, N. 2.-P. 159−166.
- Terol M.J., Lopez-Guillermo A., Bosch F. et al. Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance // J. Clin. Oncol. 1998. — Vol. 16, N. 1. -P. 35−40.
- Thaler J., Dietze O., Denz H. et al. Bone marrow diagnosis in lym-phoprolipherative disordes: comparison of results obtained from conventional histomorphology and immunohistology // Histopathology. 1991. — Vol. 18. — P. 495−504.
- Thiele J., Zirbes T.K., Kvasniska H.M. et al. Focal lymphoid aggregates in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma // J. Clin. Pathol. 1999. — Vol. 52. — P. 294 — 300.
- Tilly H., Gaulard P., Lepage E. et al. Primary anaplastic large cell lymphoma in adults: clinical presentation, immunophenotype and outcome// Blood. 1997. — Vol. 90, N. 9. — P. 3727−3734.
- Tilly H., Rossi A., Stamatoullas A. et al. Prognostic value of chromosomal abnormalities in follicular lymphoma // Blood. 1994. — Vol. 84, N. l.-P. 1043−1048.
- Torlacovic E., Torlacovic G., Brunning R.D. Follicular pattern of bone marrow involvement by follicular lymphoma // Am. J. Clin. Pathol. — 2002. Vol. 118. — P. 780 — 786.
- Traweek S.T., Sheibani K. Monocytoid B-cell lymphoma. The biologic and clinical implications of peripheral blood involvement see comments. // Am. J. Clin. Pathol. 1992. — Vol. 97, N. 1. — P. 591−598.
- Unterhalt M., Herrmann R., Nahler M. et al. Significant prolongation of disease free survival in advanced low grade non Hodgkin lymphomas (NHL) by interferon alpha maintenance // Blood. 1995. — Vol. 86, N. 10, Suppl. 1. -P. A1744 (439a).
- Vandenberghe E., De Wolf-Peeters C., van den Oord J. et al. Translocation (11- 14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage // J. Pathol. 1991. — Vol. 163, N. 1. — P. 13−19.
- Vega F., Medeiros L.J., Bueso — Ramos K. et al. Hepatosplenic gamma/delta T cell lymphoma in bone marrow // Am. J. Clin. Pathol. — 2001. -Vol. 116.-P. 410−419.
- Villuendas R., Sanchez-Beato M., Martinez J.C. et al. Loss of pl6/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression // Am. J. Pathol. 1998. — Vol. 153, N.3. -P. 887−897.
- Vitolo U., Cortellazzo S., Liberati A.M. et al. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients // Ann. Oncol. 1998. — Vol. 9, N. 1. — P. 55−61.
- Vose J.M., Sharp G., Chan W.C. et al. Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma // J. Clin. Oncol. -2002. Vol. 20, N. 9. — P. 2344−2352.
- Weisenburger D. The International Lymphoma Study Group (ILSG) Classification of non-Hodgkin's lymphoma (NHL): pathology findings from a large multicenter study // Mod. Pathol. 1997. — Vol. 10, N. 1. — P. 136A-141A.
- Weisenburger D.D., Vose J.M., Greiner T.C. et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group // Am. J. Hematol. 2000. — Vol. 64, N. 3. — P. 190−196.
- Weisenburger D.D., Vose J.M., Kollath J.P. et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 cases from the Nebraska Lymphoma Study Group // J. Clin. Oncol. 1999. — Vol. 17, N. 3. — P. 784−790.
- Weiss L.M., Crabtree G.S., Rouse R.V., Warnke R.A. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas // Am. J. Pathol.-1985.-Vol. 118, N. 1.-P. 316−322.
- Wolf Peeters C.D. Bone marrow trephine interpretation: diagnostic utility and potential pitfalls // Histopathology. — 1991. — Vol. 18. — P. 489 — 493.
- Wong K.F., Chan J.K., Chu Y.C. et al. Anaplastic large-cell lymphoma involving bone marrow // Am. J. Hemathol. — 1991. — Vol. 37. P. 112 119.
- Wong K.F., Chan J.K., Matutes E. et al. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type see comments. // Am. J. Surg. Pathol. 1995. — Vol. 19, N. 1. — P. 718−726.
- Wright D.H. What is Burkitt’s lymphoma? editorial. // J. Pathol. -1997.-Vol. 182, N. l.-P. 125−134.
- Xu Y., McKenna R.W., Asplund S.L. et al. Comparison of immuno-phenotypes of small B — cell neoplasms in primary lymph node and concurrent blood or marrow samples // Am. J. Clin. Pathol. 2002. — Vol. 118. — P. 758 764.
- Xu Y., McKenna R.W., Molberg K.H. et al. Clinicopathologic analysis of CD 10+ AND CD 10- diffuse large B-cell lymphoma // Am. J. Clin. Pathol. -2001.-Vol. 116.-P. 183−190.
- Yoshida S., Morii K., Watanabe M., Saito T. Characteristic features of malignant lymphoma with central nervous system involvement // Surg. Neurol. 2000. — Vol. 53, N. 2. — P. 163−167.
- Zemunik T., Vuckovic J., Marincovic M., Forempoher G. Bone marrow involvement and prognosis of low grade non-Hodgkin's lymphoma // Croat. Med. J. 1998. — Vol. 39, N.4. — P. 419−421.
- Zinzani P.L., Bendandi M., Martelli M. et al. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients see comments. // J. Clin. Oncol. 1996. — Vol. 14, N. 1. — P. 955−604.
- Zinzani P.L., Magagnoli M., Galieni P. et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients // J. Clin. Oncol. 1999. — Vol. 17, N. 1. — P. 1254−1259.